𩺠å
§ç§å°ç§èåç
1ïžâ£ HIV Toxoplasma Encephalitis vs PCNSL
| Lesion number |
Multiple (most) |
Single (most) |
| Lesion appearance |
Ring-enhancing |
Homogeneous enhancing |
| EBV PCR CSF |
Negative |
Positive |
| Thallium SPECT |
No uptake |
Uptake |
| FDG-PET |
Reduced uptake |
Increased uptake |
| Empirical Tx response |
Yes 1-2 wk |
No |
| Biopsy if needed |
Atypical or refractory |
Definitive |
2ïžâ£ Empirical Treatment Strategy
- HIV + CD4 < 100 + MRI ring lesions + Toxo IgG+ â empirical Toxo Tx
- 1-2 wk reassessment
- If clinical / radiographic improvement â continue (likely Toxo)
- If no improvement â brain biopsy (consider PCNSL)
- Biopsy from start if atypical features
3ïžâ£ Maternal Screening Programs
- France: universal monthly seroconversion screening
- Italy, Austria, Portugal: routine
- USA: not universal; selective + symptomatic
- WHO: not universal but consider in endemic
- Detection + spiramycin for primary infection during pregnancy
4ïžâ£ Congenital Toxoplasmosis Long-term Follow
- Ophthalmology screening lifelong (chorioretinitis reactivates)
- Audiology
- Developmental
- Neurology
- Multi-disciplinary team
5ïžâ£ Atypical Strains + Immunocompetent Severe
- South American + Tropical strains (TgCMI, TgCM2, others)
- Cause severe disease in immunocompetent (pneumonitis, retinal disease, severe mononucleosis)
- Outbreaks linked to specific source (water, soil)
- Increasing recognition
6ïžâ£ Ocular Toxoplasmosis Reactivation
- Often years-decades after congenital infection
- May be silent (one eye) or symptomatic
- Lifelong ophth surveillance for congenital cases
- Treatment of reactivation reduces visual sequelae
7ïžâ£ Transplant + Toxoplasma
- Donor-recipient transmission (D+/R-)
- Cardiac transplant especially (Toxo cysts in heart muscle)
- TMP-SMX prophylaxis post-transplant
- Monitoring + treatment if reactivation
8ïžâ£ å¥ä¿ / Taiwan
- å
¬è²» / å¥ä¿ maternal Toxo screening (in some hospitals)
- å¥ä¿ sulfadiazine + pyrimethamine + leucovorin + spiramycin for confirmed
- HIV TMP-SMX prophylaxis routine
9ïžâ£ Recent Outbreaks
- 2024-2025 reports: highly virulent S American strains
- Water contamination outbreaks (rare but ongoing)
- Recreational water concerns
10. Future + Vaccines
- Vaccine in research (animal models, clinical trials uncertain)
- Veterinary vaccine for cats (limits oocyst shedding) â not widely deployed
- Detection improvements (PCR + serology combinations)